Home / Insights / Will FDA UDI regulation be an opportunity to 3PL service provider?

insights-espresso-icon article

Will FDA UDI regulation be an opportunity to 3PL service provider?

Espresso-live Speakers
by Tejaswini Manjunath
29 September 2013

The UDI regulation announced by FDA will change things around in the supply chain for medical device logistics in USA. The regulation boast of benefits such as traceability, better access to device information, easier recalls and better reverse logistics. This study will identify the implication of UDI on 3PL service provider and how they can encash this opportunity to offer service to medical device manufacturer.   Author: Tejaswini Manjunath

SHARE
Linkedin Twitter Facebook
Leave a comment

Please enter a valid name

Post your comment

Please select captcha

Instagram

Get more stories like this

Subscirbe for more news,updates and insights from Beroe

Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

Schedule a Demo Now